LeConte Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$373K Buy
884
+44
+5% +$17.5K 0.2% 95
2026
Q2
$304K Buy
840
+80
+11% +$27.4K 0.17% 101
2026
Q1
$267K Buy
760
+52
+7% +$18.5K 0.17% 105
2025
Q4
$232K Sell
708
-28
-4% -$8.88K 0.15% 114
2025
Q3
$208K Sell
736
-40
-5% -$11.6K 0.14% 119
2025
Q2
$217K Buy
+776
New +$220K 0.15% 91

Other funds holding AMGN

LeConte Wealth Management's AMGN Position: Q3 2026 in Review

LeConte Wealth Management increased its Amgen (AMGN) stake by 5.2% in Q3 2026, buying an estimated $17.5K and bringing the position to 884 shares worth $373K. The position accounts for 0.2% of the portfolio, ranked #95.

LeConte Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 1,164 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • LeConte Wealth Management held 884 shares of Amgen worth $373K as of Q3 2026.
  • LeConte Wealth Management bought 44 Amgen shares in Q3 2026, an estimated $17.5K.
  • Amgen made up 0.2% of LeConte Wealth Management's portfolio in Q3 2026, its #95 holding.
  • LeConte Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
  • 1,164 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.